Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Volume: 381, Issue: 17, Pages: 1609 - 1620
Published: Oct 24, 2019
Abstract
The angiotensin receptor–neprilysin inhibitor sacubitril–valsartan led to a reduced risk of hospitalization for heart failure or death from cardiovascular causes among patients with heart failure and reduced ejection fraction. The effect of angiotensin receptor–neprilysin inhibition in patients with heart failure with preserved ejection fraction is...
Paper Details
Title
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Published Date
Oct 24, 2019
Volume
381
Issue
17
Pages
1609 - 1620
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History